Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Mathé

Showing results (21-30 of 34) with videos related to

Pageof 4
Sort By:
Naunyn-Schmiedeberg'S Archives of Pharmacology|October 1, 1995
Ritanserin potentiates the stimulatory effects of raclopride on neuronal activity and dopamine release selectivity in the mesolimbic dopaminergic systemJ L Andersson, G G Nomikos, M Marcus, et al.
Behavioural Brain Research|December 14, 1995
Effects of D-amphetamine and phencyclidine on behavior and extracellular concentrations of neurotensin and dopamine in the ventral striatum and the medial prefrontal cortex of the ratP Hertel, J M Mathé, G G Nomikos, et al.
Journal of Neuroscience Research|November 1, 1996
The psychotomimetic drugs D-amphetamine and phencyclidine release calcitonin gene-related peptide in the limbic forebrain of the ratA A Mathé, P Hertel, G G Nomikos, et al.
Journal of Medicinal Chemistry|February 28, 1997
Three-dimensional quantitative structure-activity relationship of melatonin receptor ligands: a comparative molecular field analysis studyS Sicsic, I Serraz, J Andrieux, et al.
Journal of Clinical Psychopharmacology|February 1, 1995
Mode of action of atypical neuroleptics in relation to the phencyclidine model of schizophrenia: role of 5-HT2 receptor and alpha 1-adrenoceptor antagonism [corrected]T H Svensson, J M Mathé, J L Andersson, et al.
European Journal of Pharmacology|July 3, 1998
Effects of WAY 100635 and (-)-5-Me-8-OH-DPAT, a novel 5-HT1A receptor antagonist, on 8-OH-DPAT responsesA C Trillat, I Malagié, M Mathé-Allainmat, et al.
European Journal of Pharmacology|June 27, 1996
Structure-activity relationships for substrates and inhibitors of pineal 5-hydroxytryptamine-N-acetyltransferase: preliminary studiesS Shen, B Brémont, I Serraz, et al.
Journal of Medicinal Chemistry|February 14, 1997
New esters of 4-amino-5-chloro-2-methoxybenzoic acid as potent agonists and antagonists for 5-HT4 receptorsD Yang, J L Soulier, S Sicsic, et al.
Journal of Medicinal Chemistry|June 9, 1995
Design and synthesis of new naphthalenic derivatives as ligands for 2-[125I]iodomelatonin binding sitesM Langlois, B Brémont, S Shen, et al.
Journal of Medicinal Chemistry|November 7, 2000
Synthesis of phenalene and acenaphthene derivatives as new conformationally restricted ligands for melatonin receptorsC Jellimann, M Mathé-Allainmat, J Andrieux, et al.
Pageof 4

Showing results (21-30 of 34) with videos related to

Sort By:
Pageof 4
Naunyn-Schmiedeberg'S Archives of Pharmacology|October 1, 1995
Ritanserin potentiates the stimulatory effects of raclopride on neuronal activity and dopamine release selectivity in the mesolimbic dopaminergic systemJ L Andersson, G G Nomikos, M Marcus, et al.
Behavioural Brain Research|December 14, 1995
Effects of D-amphetamine and phencyclidine on behavior and extracellular concentrations of neurotensin and dopamine in the ventral striatum and the medial prefrontal cortex of the ratP Hertel, J M Mathé, G G Nomikos, et al.
Journal of Neuroscience Research|November 1, 1996
The psychotomimetic drugs D-amphetamine and phencyclidine release calcitonin gene-related peptide in the limbic forebrain of the ratA A Mathé, P Hertel, G G Nomikos, et al.
Journal of Medicinal Chemistry|February 28, 1997
Three-dimensional quantitative structure-activity relationship of melatonin receptor ligands: a comparative molecular field analysis studyS Sicsic, I Serraz, J Andrieux, et al.
Journal of Clinical Psychopharmacology|February 1, 1995
Mode of action of atypical neuroleptics in relation to the phencyclidine model of schizophrenia: role of 5-HT2 receptor and alpha 1-adrenoceptor antagonism [corrected]T H Svensson, J M Mathé, J L Andersson, et al.
European Journal of Pharmacology|July 3, 1998
Effects of WAY 100635 and (-)-5-Me-8-OH-DPAT, a novel 5-HT1A receptor antagonist, on 8-OH-DPAT responsesA C Trillat, I Malagié, M Mathé-Allainmat, et al.
European Journal of Pharmacology|June 27, 1996
Structure-activity relationships for substrates and inhibitors of pineal 5-hydroxytryptamine-N-acetyltransferase: preliminary studiesS Shen, B Brémont, I Serraz, et al.
Journal of Medicinal Chemistry|February 14, 1997
New esters of 4-amino-5-chloro-2-methoxybenzoic acid as potent agonists and antagonists for 5-HT4 receptorsD Yang, J L Soulier, S Sicsic, et al.
Journal of Medicinal Chemistry|June 9, 1995
Design and synthesis of new naphthalenic derivatives as ligands for 2-[125I]iodomelatonin binding sitesM Langlois, B Brémont, S Shen, et al.
Journal of Medicinal Chemistry|November 7, 2000
Synthesis of phenalene and acenaphthene derivatives as new conformationally restricted ligands for melatonin receptorsC Jellimann, M Mathé-Allainmat, J Andrieux, et al.
Pageof 4